Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Eriksson

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Nucleic Acids Research|March 27, 2010
Identification and validation of the pathways and functions regulated by the orphan nuclear receptor, ROR alpha1, in skeletal muscleS Raichur, R L Fitzsimmons, S A Myers, et al.
The Pharmacogenomics Journal|May 11, 2005
Common VKORC1 and GGCX polymorphisms associated with warfarin doseM Wadelius, L Y Chen, K Downes, et al.
International Journal of Obesity (2005)|December 24, 2009
The Ski proto-oncogene regulates body composition and suppresses lipogenesisG M Leong, A J Kee, S M Millard, et al.
The New England Journal of Medicine|February 21, 2009
Estimation of the warfarin dose with clinical and pharmacogenetic data, T E Klein, R B Altman, et al.
European Heart Journal Open|January 5, 2023
NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patientsP Rossignol, K Duarte, E Bresso, et al.
Annals of the Rheumatic Diseases|November 21, 2008
STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase riskA-K Abelson, A M Delgado-Vega, S V Kozyrev, et al.
Journal of Internal Medicine|November 4, 2016
Extended exome sequencing identifies BACH2 as a novel major risk locus for Addison's diseaseD Eriksson, M Bianchi, N Landegren, et al.
Clinical Pharmacology and Therapeutics|April 9, 2010
Integration of genetic, clinical, and INR data to refine warfarin dosingP Lenzini, M Wadelius, S Kimmel, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Nucleic Acids Research|March 27, 2010
Identification and validation of the pathways and functions regulated by the orphan nuclear receptor, ROR alpha1, in skeletal muscleS Raichur, R L Fitzsimmons, S A Myers, et al.
The Pharmacogenomics Journal|May 11, 2005
Common VKORC1 and GGCX polymorphisms associated with warfarin doseM Wadelius, L Y Chen, K Downes, et al.
International Journal of Obesity (2005)|December 24, 2009
The Ski proto-oncogene regulates body composition and suppresses lipogenesisG M Leong, A J Kee, S M Millard, et al.
The New England Journal of Medicine|February 21, 2009
Estimation of the warfarin dose with clinical and pharmacogenetic data, T E Klein, R B Altman, et al.
European Heart Journal Open|January 5, 2023
NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patientsP Rossignol, K Duarte, E Bresso, et al.
Annals of the Rheumatic Diseases|November 21, 2008
STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase riskA-K Abelson, A M Delgado-Vega, S V Kozyrev, et al.
Journal of Internal Medicine|November 4, 2016
Extended exome sequencing identifies BACH2 as a novel major risk locus for Addison's diseaseD Eriksson, M Bianchi, N Landegren, et al.
Clinical Pharmacology and Therapeutics|April 9, 2010
Integration of genetic, clinical, and INR data to refine warfarin dosingP Lenzini, M Wadelius, S Kimmel, et al.
Pageof 4